Detalhe da pesquisa
1.
Complications and survival following percutaneous endoscopic gastrostomy tube placement.
Rev Esp Enferm Dig
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767020
2.
Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study). / Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. Resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII).
Gastroenterol Hepatol
; 2024 Jan 12.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38219960
3.
Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety.
Am J Gastroenterol
; 118(7): 1237-1247, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36716287
4.
A booster dose of SARS-COV-2 vaccine improves suboptimal seroconversion rates in patients with inflammatory bowel disease. Results of a prospective multicenter study of GETECCU (VACOVEII study).
Gastroenterol Hepatol
; 2023 Nov 23.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-38007154
5.
Translation into Spanish and validation of a short questionnaire to measure the control of inflammatory bowel disease from the patient's perspective: IBD-Control, EII-Control. / Traducción al español y validación de un cuestionario breve de medida del control de la enfermedad inflamatoria intestinal desde la perspectiva del paciente: IBD-Control, EII-Control.
Gastroenterol Hepatol
; 45(7): 524-534, 2022.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-34428475
6.
Efficacy and safety of ustekinumab in real clinical practice. Retrospective multicentre study. ARAINF cohort. / Eficacia y seguridad de ustekinumab en la práctica clínica real. Estudio multicéntrico retrospectivo. Cohorte ARAINF.
Gastroenterol Hepatol
; 43(3): 126-132, 2020 Mar.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-31866167
7.
HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients.
Inflamm Bowel Dis
; 2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462462